47 related articles for article (PubMed ID: 29486733)
1. Negative predictive value of fecal immunochemical testing in significant bowel disease screening: A systematic review and meta-analysis.
Junhai Z; Fei L; Jixiang Z; Huabing X; Cheng T; Weiguo D
Int J Surg; 2024 Jun; ():. PubMed ID: 38920326
[TBL] [Abstract][Full Text] [Related]
2. The use of faecal haemoglobin in deciding which patients presenting to primary care require further investigation (and how quickly) - the FIT approach.
Strachan JA; Mowat C
EJIFCC; 2021 Feb; 32(1):52-60. PubMed ID: 33753974
[TBL] [Abstract][Full Text] [Related]
3. FIT negative clinic as a safety net for low-risk patients with colorectal cancer: impact on endoscopy and radiology utilisation-a retrospective cohort study.
Nigam GB; Meran L; Bhatnagar I; Evans S; Malik R; Cianci N; Pakpoor J; Manganis C; Shine B; James T; Nicholson BD; East JE; Palmer RM
Frontline Gastroenterol; 2024 May; 15(3):190-197. PubMed ID: 38668989
[TBL] [Abstract][Full Text] [Related]
4. Correction: Development and validation of a simulation-based assessment tool in colonoscopy.
Jaensch C; Jensen RD; Paltved C; Madsen AH
Adv Simul (Lond); 2023 Dec; 8(1):32. PubMed ID: 38124212
[No Abstract] [Full Text] [Related]
5. Diagnostic accuracy of fecal calprotectin in predicting significant gastrointestinal diseases.
Kan YM; Chu SY; Loo CK
JGH Open; 2021 Jun; 5(6):647-652. PubMed ID: 34124380
[TBL] [Abstract][Full Text] [Related]
6. Development and evaluation of a risk assessment tool to improve clinical triage accuracy for colonoscopic investigations.
Lord AR; Simms LA; Brown A; Hanigan K; Krishnaprasad K; Schouten B; Croft AR; Appleyard MN; Radford-Smith GL
BMC Cancer; 2018 Feb; 18(1):229. PubMed ID: 29486733
[TBL] [Abstract][Full Text] [Related]
7. Evaluating a risk assessment tool to improve triaging of patients to colonoscopies.
Elliott TM; Lord A; Simms LA; Radford-Smith G; Valery PC; Gordon LG
Intern Med J; 2019 Oct; 49(10):1292-1299. PubMed ID: 30816603
[TBL] [Abstract][Full Text] [Related]
8. Appraisal of the faecal haemoglobin, age and sex test (FAST) score in assessment of patients with lower bowel symptoms: an observational study.
Digby J; Strachan JA; Mowat C; Steele RJC; Fraser CG
BMC Gastroenterol; 2019 Dec; 19(1):213. PubMed ID: 31829141
[TBL] [Abstract][Full Text] [Related]
9. REducing Colonoscopies in patients without significant bowEl DiseasE: the RECEDE Study - protocol for a prospective diagnostic accuracy study.
Bradley C; Hee SW; Andronis L; Persaud K; Hull MA; Todd J; Taylor-Phillips S; Smith S; Constable R; Waugh N; Arasaradnam RP;
BMJ Open; 2022 Mar; 12(3):e058559. PubMed ID: 35354626
[TBL] [Abstract][Full Text] [Related]
10. Patient-reported and doctor-reported symptoms when faecal immunochemical tests are requested in primary care in the diagnosis of colorectal cancer and inflammatory bowel disease: a prospective study.
Högberg C; Karling P; Rutegård J; Lilja M
BMC Fam Pract; 2020 Jul; 21(1):129. PubMed ID: 32611307
[TBL] [Abstract][Full Text] [Related]
11. Association Between Time to Colonoscopy After a Positive Fecal Test Result and Risk of Colorectal Cancer and Cancer Stage at Diagnosis.
Corley DA; Jensen CD; Quinn VP; Doubeni CA; Zauber AG; Lee JK; Schottinger JE; Marks AR; Zhao WK; Ghai NR; Lee AT; Contreras R; Quesenberry CP; Fireman BH; Levin TR
JAMA; 2017 Apr; 317(16):1631-1641. PubMed ID: 28444278
[TBL] [Abstract][Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
